Virtual Advisory Committees Are Coming: US FDA Panels Will Be Smaller, More Focused

Planning for virtual advisory committees is underway; any applications with upcoming PDUFA deadlines with meetings still on the calendar are prime candidates, OND Director Peter Stein says.

FDA Advisory Committee Feature image

The US Food & Drug Administration is moving ahead with plans to host virtual advisory committee meetings as the agency continues to respond to the need for social distancing during the COVID-19 crisis, Office of New Drug Director Peter Stein said in an interview with the Pink Sheet.

The decision to move ahead with virtual advisory committees will build on FDA’s increasing experience with online hosting of large...

More from US FDA Performance Tracker

More from Regulatory Trackers